Diabetic foot complications

Last reviewed: 3 Jun 2022
Last updated: 30 Mar 2022

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • foot ulcer
  • foot pain
  • loss of protective sensation
  • foot deformity
  • fever or chills
More key diagnostic factors

Other diagnostic factors

  • malaise
  • anorexia
  • foot erythema
  • oedema of foot, ankle, or calf
  • absent pedal pulses
  • fluctuance
Other diagnostic factors

Risk factors

  • previous history of foot ulcer
  • previous history of amputation
  • sensory neuropathy
  • peripheral arterial disease
  • end-stage renal disease
  • Charcot midfoot deformity
  • structural forefoot deformities
  • limited ankle joint mobility (ankle equinus)
  • visual impairment
  • poor glycaemic control
More risk factors

Diagnostic investigations

1st investigations to order

  • FBC
  • blood glucose level
  • x-ray foot
More 1st investigations to order

Investigations to consider

  • microbiological culture
  • erythrocyte sedimentation rate
  • C-reactive protein
  • ankle/toe pressures
  • renal function
  • angiography
  • MR angiography
  • CT angiography
  • MRI foot
  • arterial duplex ultrasound
More investigations to consider

Emerging tests

  • serum procalcitonin
  • 18F-fluorodeoxyglucose (FDG)-PET/CT

Treatment algorithm

ACUTE

at initial presentation

ONGOING

after initial definitive treatment

Contributors

Authors

Frances L. Game, MBBCh, FRCPath

Consultant Diabetologist and Clinical Director of R&D

Department of Diabetes and Endocrinology

University Hospitals of Derby and Burton NHS Foundation Trust

Derby

UK

Disclosures

FLG is an author of a reference cited in the topic.

Acknowledgements

Dr Frances L. Game would like to gratefully acknowledge Dr Neal R. Barshes, Dr Joseph L. Mills, and Dr David G. Armstrong, previous contributors to this topic.

Disclosures

NRB and DGA declare that they have no competing interests. JLM is a consultant for, and owns stocks in, Nangio TX; a member of the scientific advisory committees for Cesca, AnGes, and AstraZeneca; and the Co-National Principal Investigator for the Voyager trial of rivaroxaban in peripheral arterial disease patients undergoing intervention (funding for this institutional research grant goes directly to the Baylor College of Medicine).

Peer reviewers

Simon Ashwell, MBChB, MD, FRCP

Consultant Physician of Diabetes and Endocrinology

Diabetes Care Centre

The James Cook University Hospital

Middlesbrough

UK

Disclosures

SA declares that he has no competing interests.

  • Diabetic foot complications images
  • Differentials

    • Venous leg ulcer
    • Gout
    • Acute Charcot arthropathy
    More Differentials
  • Guidelines

    • Standards of medical care in diabetes - 2022
    • 2021 evidence-based Australian guidelines for diabetes-related foot disease
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer